| Application no. and date | 22769624.2 (espacenet) (Federated) (European Patent Register), 20220826 | | Patent/reg. no. and date | DK/EP 4244252, 20240529 | | Publication date | 20230920 | | Priority no. and date | US 202163237630 P, 20210827, US 202263364734 P, 20220516 | | EP pub. no. and date |
EP 4244252 20230920 | | Effective date | | | Applicant/owner | MedImmune Limited, 1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 0AA, GB | | Applicant ref. no. | 1705486 | | Inventor | SADIQ, Muhammad Waqas,
151 85 Södertälje, SE,
LOZANO, Eulalia Jimenez,
28033 Madrid, ES | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61P 37/06 (2006.01) , C07K 16/24 (2006.01) | | Title | BEHANDLING AF KRONISK OBSTRUKTIV LUNGESYGDOM MED ET ANTI-INTERLEUKIN-33-ANTISTOF | | Int. application no. | EP2022073766 | | Int. publication no. | WO2023025932 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
